The antimelanoma differentiation‐associated gene 5 (anti‐MDA5) antibody (Ab) was first discovered in a Japanese patient cohort with clinically amyopathic dermatomyositis (CADM) in 2005.1 This evidence concerns the gene IFIH1 and dermatomyositis.